WAG
VTVT icon

Winthrop Advisory Group’s vTv Therapeutics VTVT Stock Holding History

Winthrop Advisory Group’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-76
Closed -$409K – 151
2021
Q3 		$409K Hold
76
– – 0.09% 70
2021
Q2 		$416K Buy
76
+10
+15% +$1.01K 0.09% 74
2021
Q1 		$347K Buy
66
+3
+5% +$295 0.09% 85
2020
Q4 		$300K Buy
+63
New +$4.83K 0.08% 95

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Winthrop Advisory Group's VTVT Position: Q4 2021 in Review

Winthrop Advisory Group sold out of vTv Therapeutics (VTVT) in Q4 2021, closing a stake of 76 shares — an estimated $409K sold.

Winthrop Advisory Group first reported a position in VTVT in Q4 2020 and held it in 4 quarters. The position peaked at $416K in Q2 2021. 29 funds tracked by Wall St. Rank hold VTVT as of Q4 2021.

  • Winthrop Advisory Group reported no remaining vTv Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Winthrop Advisory Group sold 76 vTv Therapeutics shares in Q4 2021, an estimated $409K.
  • Winthrop Advisory Group first reported a position in vTv Therapeutics in Q4 2020 and held it in 4 quarters.
  • Winthrop Advisory Group's vTv Therapeutics position peaked at $416K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2021.

Based on Winthrop Advisory Group's 13F filing for Q4 2021, filed 12 Jan 2022.